This study focused on neurodegenerative biomarkers in multiple sclerosis—namely, plasma neurofilament light chain (pNfL) levels and magnetic resonance imaging (MRI)-based brain volume measurements. This evidence concerns the gene NEFL and multiple sclerosis.